Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Watchlist Manager
Sun Pharmaceutical Industries Ltd Logo
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Watchlist
Price: 1 795.3 INR 0.86% Market Closed
Market Cap: 4.3T INR
Have any thoughts about
Sun Pharmaceutical Industries Ltd?
Write Note

Wall Street
Price Targets

SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd

Wall Street analysts forecast SUNPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 015.61 INR with a low forecast of 1 344.31 INR and a high forecast of 2 572.5 INR.

Lowest
Price Target
1 344.31 INR
25% Downside
Average
Price Target
2 015.61 INR
12% Upside
Highest
Price Target
2 572.5 INR
43% Upside
Sun Pharmaceutical Industries Ltd Competitors:
Price Targets
4547
Kissei Pharmaceutical Co Ltd
7% Upside
ITCI
Intra-Cellular Therapies Inc
19% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
24% Upside
AHEALTH
Apex Healthcare Bhd
13% Upside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
20% Upside
ORNBV
Orion Oyj
11% Upside
4519
Chugai Pharmaceutical Co Ltd
19% Upside

Revenue
Forecast

Revenue Estimate
Sun Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's revenue is 7%. The projected CAGR for the next 3 years is 10%.

7%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sun Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's operating income is 4%. The projected CAGR for the next 3 years is 14%.

4%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Sun Pharmaceutical Industries Ltd

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's net income is 10%. The projected CAGR for the next 3 years is 15%.

10%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SUNPHARMA's stock price target?
Price Target
2 015.61 INR

According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 015.61 INR with a low forecast of 1 344.31 INR and a high forecast of 2 572.5 INR.

What is Sun Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's revenue is 7%. The projected CAGR for the next 3 years is 10%.

What is Sun Pharmaceutical Industries Ltd's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's operating income is 4%. The projected CAGR for the next 3 years is 14%.

What is Sun Pharmaceutical Industries Ltd's Net Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Sun Pharmaceutical Industries Ltd's net income is 10%. The projected CAGR for the next 3 years is 15%.

Back to Top